Implied Volatility Surging for Puma Biotechnology (PBYI) Stock Options

20.05.24 15:59 Uhr

Werte in diesem Artikel
Aktien

2,80 EUR -0,07 EUR -2,51%

43,57 EUR -0,57 EUR -1,29%

Indizes

PKT PKT

1.576,3 PKT 16,3 PKT 1,05%

509,0 PKT 6,3 PKT 1,26%

25.589,6 PKT 127,4 PKT 0,50%

25.715,8 PKT 244,0 PKT 0,96%

12.629,7 PKT 119,8 PKT 0,96%

7.169,5 PKT 71,9 PKT 1,01%

Investors in Puma Biotechnology, Inc. PBYI need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 20, 2024 $2.50 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.What do the Analysts Think?Clearly, options traders are pricing in a big move for Puma Biotechnology shares, but what is the fundamental picture for the company? Currently, Puma Biotechnology is a Zacks Rank #3 (Hold) in the Medical - Biomedical and Genetics industry that ranks in the Top 35% of our Zacks Industry Rank. Over the last 60 days, our Zacks Consensus Estimate for the current quarter has moved from 16 cents per share to 1 cent in that period.Given the way analysts feel about Puma Biotechnology right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.Looking to Trade Options?Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.Click to see the trades now >>Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Puma Biotechnology, Inc. (PBYI): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Puma Biotechnology

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Puma Biotechnology

NameHebelKOEmittent
NameHebelKOEmittent
Werbung

Quelle: Zacks

Nachrichten zu PUMA SE

Analysen zu PUMA SE

DatumRatingAnalyst
17.06.2024PUMA SE NeutralJP Morgan Chase & Co.
05.06.2024PUMA SE Sector PerformRBC Capital Markets
03.06.2024PUMA SE HoldJefferies & Company Inc.
03.06.2024PUMA SE Sector PerformRBC Capital Markets
17.05.2024PUMA SE Equal WeightBarclays Capital
DatumRatingAnalyst
10.05.2024PUMA SE BuyHauck Aufhäuser Lampe Privatbank AG
10.05.2024PUMA SE BuyWarburg Research
09.05.2024PUMA SE BuyDeutsche Bank AG
09.05.2024PUMA SE BuyGoldman Sachs Group Inc.
08.05.2024PUMA SE AddBaader Bank
DatumRatingAnalyst
17.06.2024PUMA SE NeutralJP Morgan Chase & Co.
05.06.2024PUMA SE Sector PerformRBC Capital Markets
03.06.2024PUMA SE HoldJefferies & Company Inc.
03.06.2024PUMA SE Sector PerformRBC Capital Markets
17.05.2024PUMA SE Equal WeightBarclays Capital
DatumRatingAnalyst
20.09.2021PUMA SE VerkaufenDZ BANK
06.07.2021PUMA SE VerkaufenDZ BANK
28.04.2021PUMA SE VerkaufenDZ BANK
23.04.2021PUMA SE VerkaufenDZ BANK
09.04.2021PUMA SE VerkaufenDZ BANK

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für PUMA SE nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"